|
Disease variable
|
Estimated VO2peak
|
p-value
|
Walking distance
|
p-value
|
|---|
|
Use of any medication
|
−0.07
|
0.59
|
−0.10
|
0.47
|
|
Use of synthetic DMARDs
|
0.04
|
0.79
|
−0.04
|
0.76
|
|
Use of biologic DMARDs
|
−0.03
|
0.80
|
0.02
|
0.81
|
|
JADAS 71 (0–101)
|
−0.03
|
0.84
|
0.08
|
0.54
|
|
CHAQ (0–3)
|
−0.13
|
0.35
|
−0.18
|
0.17
|
|
Active joints
|
0.10
|
0.48
|
0.21
|
0.16
|
|
Active joints in the lower extremities
|
0.09
|
0.46
|
0.20
|
0.13
|
|
Disease duration (years)
|
−0.13
|
0.34
|
0.00
|
0.97
|
|
Pain, current (NRS 0–10)
|
−0.21
|
0.11
|
−0.13
|
0.31
|
|
Pain, previous week (NRS 0–10)
|
−0.16
|
0.24
|
−0.02
|
0.88
|
|
Fatigue, previous week (NRS 0–10)
|
−0.07
|
0.58
|
−0.02
|
0.87
|
- JIA juvenile idiopathic arthritis, DMARDs disease modifying anti-rheumatic drugs, JADAS juvenile arthritis disease activity score, CHAQ childhood health assessment questionnaire, NRS numeric rating scale, VO2peak peak oxygen uptake
